PPAR alpha

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

DyslipidemiaHypercholesterolemiaMild Hypertension

Phase 2

A Study in People With Abnormal Fat Levels in the Blood

CompletedNCT00116519

Eli Lilly and CompanyDyslipidemia

Start: 2005-07-31End: 2006-10-31Target: 300Updated: 2007-01-26

A Study in People With High Cholesterol

CompletedNCT00133380

Eli Lilly and CompanyHypercholesterolemia

Start: 2005-07-31End: 2006-09-30Target: 300Updated: 2007-04-06

A Study in People With Mild Hypertension

CompletedNCT00374855

Eli Lilly and CompanyMild Hypertension

Start: 2006-09-30End: 2006-11-30Target: 153Updated: 2007-05-15

Related Papers

Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.

2007-03-2585 citations